¼¼°èÀÇ Çì¸ð±Û·Îºó A1c(HbA1c) °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Hemoglobin A1c (HbA1c) Testing Global Market Report 2025
»óǰÄÚµå : 1704509
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,342,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,167,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,992,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Çì¸ð±Û·Îºó A1c(HbA1c) °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ 10.5%ÀÇ ¼ºÀå·ü·Î 2029³â±îÁö 30¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ È®´ë, ¸ÂÃãÇü ÀÇ·á ¹× È¯ÀÚ Áß½É Ä¡·áÀÇ Áõ°¡, ±ÔÁ¦ Áö¿ø ¹× »óȯ Á¤Ã¥, ¿ø°ÝÀÇ·áÀÇ È®´ë, ¿ø°Ý ¸ð´ÏÅ͸µ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, µðÁöÅÐ Çコ Ç÷§Æû°úÀÇ ÅëÇÕ, ºñħ½ÀÀû °Ë»ç ±â¼úÀÇ ¹ßÀü, ¿ø°ÝÀÇ·áÀÇ È®´ë, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

´ç´¢º´ À¯º´·üÀÇ Áõ°¡´Â Çì¸ð±Û·Îºó A1c(HbA1c) °Ë»ç ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´Àº ºÒÃæºÐÇÑ Àν¶¸° ºÐºñ ¶Ç´Â Àν¶¸° ÀúÇ×¼ºÀ¸·Î ÀÎÇØ ½Åü°¡ Ç÷´çÀ» Á¶ÀýÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ´Â ¸¸¼ºÁúȯÀÔ´Ï´Ù. ´ç´¢º´ ȯÀÚÀÇ Áõ°¡´Â ½Ä½À°ü, ƯÈ÷ °¡°ø½Äǰ°ú ¼³ÅÁÀÌ Ã·°¡µÈ À½·áÀÇ °ú´Ù ¼·Ãë, ½Åü Ȱµ¿À» ÃÖ¼ÒÈ­ÇÏ´Â ÁÂ½Ä »ýȰ½À°ü µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, °í·ÉÈ­¿Í À¯ÀüÀû ¼ÒÀÎÀÌ ´ç´¢º´ ¹ßº´ °¡´É¼ºÀ» ³ôÀ̰í ÀÖÀ¸¸ç, HbA1c °Ë»ç´Â Áö³­ 2-3°³¿ù°£ÀÇ Æò±Õ Ç÷´ç ¼öÄ¡¸¦ ÃøÁ¤ÇÏ¿© Àå±âÀûÀÎ Ç÷´ç Á¶ÀýÀ» ¸ð´ÏÅ͸µÇÏ´Â µ¥ ÇʼöÀûÀÎ °Ë»çÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù LancetÁö µ¥ÀÌÅÍ¿¡ µû¸£¸é Àü ¼¼°è ´ç´¢º´ ȯÀÚ´Â 2021³â 5¾ï 2,900¸¸ ¸í¿¡¼­ 2050³â 13¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °á°úÀûÀ¸·Î ´ç´¢º´ À¯º´·üÀÇ Áõ°¡´Â HbA1c °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

HbA1c °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ´ç´¢º´ Áø´Ü ¹× ¸ð´ÏÅ͸µÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ °í¼º´É ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ(HPLC) ±â¼úÀ» ÀÌ¿ëÇÑ ÀÚµ¿ ºÐ¼®±â µîÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´ ȯÀÚÀÇ Àå±âÀûÀÎ Ç÷´ç Á¶ÀýÀ» ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 6¿ù ÀεµÀÇ ÀÇ·á ±â¼ú ȸ»çÀÎ Trivitron Healthcare Private Limited´Â NANO H5¿Í NANO H110À» Ãâ½ÃÇߴµ¥, NANO H5´Â 130ÃÊÀÇ Ã³¸® ½Ã°£À¸·Î ÀüÇ÷ÀÇ ´çÈ­Ç÷»ö¼Ò(HbA1c)¸¦ Á¤·®ÇÏ´Â ¼ÒÇü ÀÚµ¿ HPLC ºÐ¼®±âÀÔ´Ï´Ù. ºü¸¥ °Ë»ç °á°ú¿Í ÃÖ´ë 5°³ ½Ã·áÀÇ µ¿½Ã 󸮰¡ °¡´ÉÇÑ ¼ÒÇü ÀÚµ¿ HPLC ºÐ¼®±âÀ̸ç, NANO H110 ¿ª½Ã HbA1c¿Í Hb º¯ÀÌü °ËÃâÀÇ µà¾ó °Ë»ç ¸ðµå¸¦ °®Ãá ¼ÒÇü ÀÚµ¿ HPLC ºÐ¼®±âÀÔ´Ï´Ù. ¹ÙÄÚµå ½ºÄ³³Ê ¹× ĸ ÇǾî½Ì°ú °°Àº ÷´Ü ±¸¼º¿ä¼Ò¸¦ žÀçÇϰí, 110°³ ½Ã·áÀÇ ³ôÀº ½Ã·á ¿ë·®À» °®Ãß°í ÀÖ¾î Áß´ëÇü °Ë»ç½Ç¿¡ ÀûÇÕÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c (HbA1c) testing market size has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing awareness and screening programs, growing government initiatives and healthcare policies, increasing healthcare infrastructure development, a growing aging population, improved diagnostic accuracy, and increased adoption of point-of-care testing.

The hemoglobin a1c (HbA1c) testing market size is expected to see rapid growth in the next few years. It will grow to $3.02 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising prevalence of lifestyle diseases, increased focus on preventive healthcare, expansion in emerging markets, increasing personalized medicine and patient-centric care, regulatory support and reimbursement policies, growing telemedicine, and remote monitoring. Major trends in the forecast period include technological advancements, integration with digital health platforms, advancements in non-invasive testing technologies, expansion in telehealth, and remote patient monitoring.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hemoglobin a1c (hba1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemoglobin a1c (hba1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hemoglobin A1c (HbA1c) Testing Growth Analysis And Strategic Analysis Framework

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

9. China Hemoglobin A1c (HbA1c) Testing Market

10. India Hemoglobin A1c (HbA1c) Testing Market

11. Japan Hemoglobin A1c (HbA1c) Testing Market

12. Australia Hemoglobin A1c (HbA1c) Testing Market

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

16. UK Hemoglobin A1c (HbA1c) Testing Market

17. Germany Hemoglobin A1c (HbA1c) Testing Market

18. France Hemoglobin A1c (HbA1c) Testing Market

19. Italy Hemoglobin A1c (HbA1c) Testing Market

20. Spain Hemoglobin A1c (HbA1c) Testing Market

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

22. Russia Hemoglobin A1c (HbA1c) Testing Market

23. North America Hemoglobin A1c (HbA1c) Testing Market

24. USA Hemoglobin A1c (HbA1c) Testing Market

25. Canada Hemoglobin A1c (HbA1c) Testing Market

26. South America Hemoglobin A1c (HbA1c) Testing Market

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

29. Africa Hemoglobin A1c (HbA1c) Testing Market

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

34. Recent Developments In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â